Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.8K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pandemic-era increases in late-stage pediatric cancer diagnoses, 2020-2022.

JNCI cancer spectrum·2026
Same author

Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Developing a pan cancer therapy based on DISE-inducing short RNAs.

Molecular therapy. Nucleic acids·2026
Same author

EZH1/2 inhibition improves immunotherapy response through MHC Class II de-repression and neutrophil reprogramming.

bioRxiv : the preprint server for biology·2026
Same author

JCO Clinical Cancer Informatics Special Series on Catchment Area Analysis.

JCO clinical cancer informatics·2026
Same author

A Cross-Sectional Assessment of Differences in the U.S. Health Care Workforce by Urbanicity, 2019 to 2023.

Annals of internal medicine·2026
Same journal

Examining implementation strategies to reduce disparities in lung cancer screening uptake by state Medicaid expansion status: a scoping review.

Preventive oncology & epidemiology·2026
Same journal

Cancer screening information-seeking before and during the COVID-19 pandemic.

Preventive oncology & epidemiology·2026
Same journal

STEPS (Study To Examine Parent, Patient/Dental Provider Systems) to prevent human papillomavirus (HPV)-related cancers: A formative assessment of HPV educational engagement of the dental practice.

Preventive oncology & epidemiology·2025
Same journal

Approaches to address common barriers to colorectal cancer screening in rural communities of the CDC's colorectal cancer control program.

Preventive oncology & epidemiology·2025
Same journal

Promising approaches to support sustained colorectal cancer screening promotion strategies in primary care clinics.

Preventive oncology & epidemiology·2025
Same journal

CHAT-S Study Protocol: A randomized controlled trial of a health insurance literacy education program for young adult cancer survivors.

Preventive oncology & epidemiology·2025
See all related articles

Related Experiment Video

Updated: May 6, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.5K

Enhancing Catchment Area Tools: A De-Identification Method for Integrating Clinical Trial Data with Cancer InFocus.

Daniel Antonio1, Todd Burus2, Tarneka M Manning1

  • 1Robert H Lurie Comprehensive Cancer Center, Northwestern University.

Preventive Oncology & Epidemiology
|March 3, 2025
PubMed
Summary
This summary is machine-generated.

Geographic aggregation de-identifies clinical trial data, enhancing cancer surveillance. This method ensures Health Insurance Portability and Accountability Act (HIPAA) compliance, revealing disparities and guiding cancer research and outreach efforts.

Keywords:
Catchment AreaClinical Trial AccrualData VisualizationGeographic AggregationNCI Cancer Center

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.8K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.8K

Related Experiment Videos

Last Updated: May 6, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

20.5K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

8.8K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.8K

Area of Science:

  • Cancer research
  • Public health surveillance
  • Health informatics

Background:

  • National Cancer Institute (NCI)-designated cancer centers monitor cancer burden in catchment areas.
  • Data visualization tools like Cancer InFocus aid research and outreach.
  • Clinical trial accrual data can improve catchment area understanding but requires de-identification per Health Insurance Portability and Accountability Act (HIPAA).

Purpose of the Study:

  • Introduce a HIPAA-compliant de-identification method using geographic aggregation.
  • Enable comprehensive catchment area surveillance by integrating clinical trial data.
  • Enhance understanding of cancer burden and disparities within NCI-designated cancer center catchment areas.

Main Methods:

  • Geocode patient home addresses from clinical trials to census tracts.
  • Merge census tracts with fewer than 20 patient accruals using geographic aggregation.
  • Conduct risk assessment for re-identification and calculate accrual rates for integration into Cancer InFocus.

Main Results:

  • Geographic aggregation successfully merged tracts, maintaining low re-identification risk.
  • The method exceeded the 20-patient threshold for all merged tracts.
  • Identified disparities between clinical trial accruals and social determinants of health.

Conclusions:

  • Geographic aggregation is a HIPAA-compliant method for de-identifying clinical trial data.
  • This approach enhances catchment area surveillance and supports targeted cancer research and outreach.
  • The integrated data reveals area-specific needs and health disparities.